Clinical Research Directory
Browse clinical research sites, groups, and studies.
VItamiN D treatIng Chronic heArT Failure (the Effect of Vitamin D Supplementation in Patients With Heart Failure)
Sponsor: University of Leeds
Summary
VINDICATE 2 will be a randomised, placebo-controlled, parallel group, double-blind study of vitamin D versus placebo in otherwise optimally-managed patients with CHF due to LVSD and vitamin D deficiency (\<50nmol/L). The intervention will be a daily dose of 4000IU (100µg) per day or matching placebo for a minimum of 2 years and a maximum of 4 years.
Official title: VItamiN D treatIng Chronic heArT Failure (the Effect of Vitamin D Supplementation on Hospitalisation and Mortality in Patients With Heart Failure): Multicentre, Phase III, Randomised Placebo-controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1253
Start Date
2023-12-01
Completion Date
2027-03-01
Last Updated
2022-11-02
Healthy Volunteers
No
Conditions
Interventions
4000IU Vitamin D3
Chewable blackcurrant flavoured tablets (two per day)
Locations (1)
Leeds General Infirmary
Leeds, United Kingdom